meta
|
evidence
oncology
Living systematic review and meta-analysis
metastatic/advanced - breast cancer (mBC)
1
cervical cancer (CC)
classical Hodgkin lymphoma (cHL)
immune chekpoint inhibitors
anti-PD-(L)1
pembrolizumab based treatment
pembrolizumab alone